Immune-stimulating drug before surgery shows promise in early-stage pancreatic cancer ...Middle East

- News
Immune-stimulating drug before surgery shows promise in early-stage pancreatic cancer
Giving early-stage pancreatic cancer patients a CD40 immune-stimulating drug helped jumpstart a T cell attack to the notoriously stubborn tumor microenvironment before surgery and other treatments, according to a new study from researchers in the Abramson Cancer Center at the University of Pennsylvania.

Hence then, the article about immune stimulating drug before surgery shows promise in early stage pancreatic cancer was published today ( ) and is available on ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Immune-stimulating drug before surgery shows promise in early-stage pancreatic cancer )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News